drugset
drugset / Trial / NCT02074735

Citicoline for Alcohol Dependence

NCT02074735 ↗

Phase 4 Completed 62 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if citicoline, as an add-on therapy, will help reduce alcohol use in outpatients with alcohol dependence.

Timeline

Start
2014-04
Primary completion
2016-10
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citicoline Other / unclassified 2000 mg —

Indications

alcohol dependence